Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001829126-25-002940
Filing Date
2025-04-25
Accepted
2025-04-25 14:38:00
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-1 cyclacel_s1.htm S-1 1001145
2 EXHIBIT 5.1 cyclacel_ex5-1.htm EX-5.1 11439
3 EXHIBIT 23.1 cyclacel_ex23-1.htm EX-23.1 4959
4 EXHIBIT 107 cyclacel_ex107.htm EX-FILING FEES 27094
5 GRAPHIC img_001.jpg GRAPHIC 7951
6 GRAPHIC ex5-1_001.jpg GRAPHIC 30423
7 GRAPHIC ex23-1_001.jpg GRAPHIC 22772
  Complete submission text file 0001829126-25-002940.txt   1130104
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-286754 | Film No.: 25872982
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)